CN1190229C - Medicine for curing hepatitis B - Google Patents
Medicine for curing hepatitis B Download PDFInfo
- Publication number
- CN1190229C CN1190229C CNB031186017A CN03118601A CN1190229C CN 1190229 C CN1190229 C CN 1190229C CN B031186017 A CNB031186017 A CN B031186017A CN 03118601 A CN03118601 A CN 03118601A CN 1190229 C CN1190229 C CN 1190229C
- Authority
- CN
- China
- Prior art keywords
- radix
- herba
- medicine
- root
- hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a traditional Chinese medicine for treating hepatitis B, which is mainly prepared from stringy stonecrop herb, virgate wormwood herb, purslane herb, red peony root, red sage root, giant knotweed rhizome, oldenlandia, Chinese angelica, Chinese magnolivine fruit, tuckahoe, lightyellow sophora root, curcuma root, milkvetch root, China siphonostegia, malt, gizzard membrane, stir-baked Massa Medicata Fermentata and the like as raw materials. The traditional Chinese medicine has the advantages of wide medicine source, easy acquisition, low cost, no toxicity and harm to human bodies, high safety and reliability for medication, short treatment course, rapid effect and obvious curative effect.
Description
(1) technical field:
The present invention relates to a kind of medicine for the treatment of hepatitis B, is the Chinese medicine preparation of treatment hepatitis B specifically.
(2) technical background:
Hepatitis B is the higher infectious disease of a kind of sickness rate, especially in China, hepatitis B patient and virus carrier are up to people more than 100,000,000, account for 10% of country's total population, in some high region of disease, hepatitis B patient reaches more than 70% unexpectedly, present stage is the traditional Chinese medical science or doctor trained in Western medicine no matter, treatment to hepatitis B does not all have specially good effect, especially in the rural area, owing to reasons such as treatment instability, treatment phase length, expense height, cause some hepatitis B patients to develop into liver cirrhosis even hepatocarcinoma, all cause very big injury for patient and family.
(3) summary of the invention:
The object of the present invention is to provide a kind of Chinese medicine preparation of effective treatment hepatitis B, through clinical verification, medicine of the present invention has effects such as obviously killing hepatitis B virus, promotion liver cell regeneration, enhancing liver immunity.
Medicine of the present invention is to make (by weight) by following raw material:
Herba Sedi 7-10 Herba Artemisiae Scopariae 7-10
Herba Portulacae 7-10 Radix Paeoniae Rubra 5.5-7.5
Radix Salviae Miltiorrhizae 5.5-7.5 Rhizoma Polygoni Cuspidati 5.5-7.5
Herba Hedyotidis Diffusae 5.5-7.5 Radix Angelicae Sinensis 5.5-7.5
Fructus Schisandrae Chinensis 5.5-7.5 Poria 5.5-7.5
Radix Sophorae Flavescentis 5.5-7.5 Radix Curcumae 5.5-7.5
Radix Astragali 5.5-7.5 Herba Siphonostegiae 5.5-7.5
Fructus Hordei Germinatus 5.5-7.5 Endothelium corneum 5.5-7.5
Massa Medicata Fermentata (parched to brown) 5.5-7.5
Above-mentioned each component preferred weight proportioning is:
Herba Sedi 8 Herba Artemisiae Scopariaes 8
Herba Portulacae 8 Radix Paeoniae Rubra 6
Radix Salviae Miltiorrhizae 6 Rhizoma Polygoni Cuspidati 6
Herba Hedyotidis Diffusae 6 Radix Angelicae Sinensis 6
Fructus Schisandrae Chinensis 6 Poria 6
Radix Sophorae Flavescentis 6 Radix Curcumaes 6
The Radix Astragali 6 Herba Siphonostegiae 6
Fructus Hordei Germinatus 6 Endothelium corneum 6
Massa Medicata Fermentata (parched to brown) 6
The preparation method of medicine of the present invention is:
With the selected raw material of said medicine, be ground into fine powder after the oven dry, after the sieve mixing, per 100 grams add 20-40 gram refined honey and low amounts of water, make water-honeyed pill, dry again getting final product.
Perhaps,, be ground into fine powder after the oven dry, further pulverize behind the mix homogeneously, cross 100 mesh sieves, incapsulate and to get the selected raw material of said medicine.
The clinical use result of medicine 1995-2001 of the present invention shows, has the following advantages:
1, our medicine source is extensive, easily adopts to be easy to get, and is with low cost;
2, we adopt natural drug, and nontoxic to human body, drug safety is reliable;
3, production technology is simple, taking convenience, and short treating period, instant effect, and evident in efficacy.
For showing the therapeutic effect of medicine of the present invention to hepatitis B, the present invention is through clinical observation, and data is as follows:
1, case choice criteria:
Traditional medicine thinks that the hepatitis B pathogenesis is: damp and hot surplus heresy is not most, stagnation of liver-QI with deficiency of the spleen, and QI and blood deficiency is so the differential diagnosis in tcm standard is: refreshing tired power, the soreness of waist, dizziness, tinnitus, dim eyesight, red tongue, thready and stringy pulse.
2, diagnostic criteria:
" viral hepatitis is prevented and treated scheme " of Shanghai meeting revision is diagnostic criteria with nineteen ninety, and hepatitis history surpasses half a year, and more than one positive signs that have present situation HBV to infect.
3, curative effect judging standard:
Related content with 1993 " traditional Chinese medical science Clinical Researches of New Drugs guideline " first volume is a curative effect judging standard.Produce effects: symptom, sign disappear, and liver function is normal, and the hbv replication index all disappears; Effectively: symptom and liver function are all improved or the hbv replication index has more than one and turns out cloudy; Invalid: symptom, sign do not change, and liver function is not improved.
4, physical data:
Select case 500 examples altogether by standard: 500 examples are organized in treatment, and great three positive has 225 examples, and small three positive has 190 examples, HBsAg carrier 85 examples, male's 382 examples wherein, women's 118 examples, 40.5 years old mean age, average course of disease 2.8 years; Matched group 100 examples, great three positive has 51 examples, and small three positive has 38 examples, HBsAg carrier 11 examples, male's 72 examples wherein, women's 28 examples, 39.6 years old mean age, average course of disease 2.6 years.
Administrated method and consumption: the treatment group is taken medicine of the present invention, and is oral, every day 3 times, and one time 5 gram, 3 months is a course of treatment; Matched group is taken " hepatitis B recuperating medicine capsule ", and is oral, every day 3 times, and one time 12 gram, 3 months is a course of treatment.
Result such as following table:
The treatment group hepatitis B patient situation observation table of turning out cloudy
Table 1:
Type | Before the treatment | After the treatment | |||||||||||
The case sum | HBsAg | Anti-HBs | HBeAg | Anti-HBe | Anti-HBc | The number of turning out cloudy | Do not change number | HBsAg | Anti-HBs | HBeAg | Anti-HBe | Anti-HBc | |
Great three positive | 225 | + | - | + | - | + | 216 | - | + | - | - | - | |
9 | + | - | + | - | - | ||||||||
Small three positive | 190 | + | - | - | + | + | 182 | - | + | - | - | - | |
8 | + | - | - | + | + | ||||||||
Carrier | 85 | + | - | - | - | - | 82 | - | + | - | - | - | |
3 | + | - | - | - | - | ||||||||
Add up to | 500 | 480 | 20 |
Treatment group and matched group effective percentage comparison sheet
Table 2:
Group | Example number (%) | Produce effects (%) | Effectively (%) | Invalid (%) | Total effective rate (%) |
The treatment group | 500 | 288(57.6) | 192(38.4) | 20(4) | 96 |
Matched group | 100 | 32(32) | 30(30) | 38(38) | 62 |
Result of study shows: take medicine of the present invention, obvious effective rate is 57.6%, and effective percentage is 38.4%, and total effective rate is 96%, obviously is better than matched group at aspects such as killing hepatitis B virus, promotion liver cell regeneration, enhancing liver immunity.
(4), embodiment:
Get raw material (gram) by following proportioning
Herba Sedi 8 Herba Artemisiae Scopariaes 8
Herba Portulacae 8 Radix Paeoniae Rubra 6
Radix Salviae Miltiorrhizae 6 Rhizoma Polygoni Cuspidati 6
Herba Hedyotidis Diffusae 6 Radix Angelicae Sinensis 6
Fructus Schisandrae Chinensis 6 Poria 6
Radix Sophorae Flavescentis 6 Radix Curcumaes 6
The Radix Astragali 6 Herba Siphonostegiae 6
Fructus Hordei Germinatus 6 Endothelium corneum 6
Massa Medicata Fermentata (parched to brown) 6
Preparation method is as follows:
With the selected raw material of said medicine, be ground into fine powder after the oven dry, after the sieve mixing, per 100 grams add 20-40 gram refined honey and low amounts of water, make water-honeyed pill, dry again getting final product.
Perhaps,, be ground into fine powder after the oven dry, further pulverize behind the mix homogeneously, cross 100 mesh sieves, incapsulate and to get the selected raw material of said medicine.
Claims (2)
1, a kind of medicine for the treatment of hepatitis B is characterized in that it is the medicament of being made by the following weight proportion raw material:
Herba Sedi 7-10 Herba Artemisiae Scopariae 7-10
Herba Portulacae 7-10 Radix Paeoniae Rubra 5.5-7.5
Radix Salviae Miltiorrhizae 5.5-7.5 Rhizoma Polygoni Cuspidati 5.5-7.5
Herba Hedyotidis Diffusae 5.5-7.5 Radix Angelicae Sinensis 5.5-7.5
Fructus Schisandrae Chinensis 5.5-7.5 Poria 5.5-7.5
Radix Sophorae Flavescentis 5.5-7.5 Radix Curcumae 5.5-7.5
Radix Astragali 5.5-7.5 Herba Siphonostegiae 5.5-7.5
Fructus Hordei Germinatus 5.5-7.5 Endothelium corneum 5.5-7.5
Massa Medicata Fermentata (parched to brown) 5.5-7.5.
2, the medicine of treatment hepatitis B as claimed in claim 1, wherein the weight proportion of each raw material is:
Herba Sedi 8 Herba Artemisiae Scopariaes 8
Herba Portulacae 8 Radix Paeoniae Rubra 6
Radix Salviae Miltiorrhizae 6 Rhizoma Polygoni Cuspidati 6
Herba Hedyotidis Diffusae 6 Radix Angelicae Sinensis 6
Fructus Schisandrae Chinensis 6 Poria 6
Radix Sophorae Flavescentis 6 Radix Curcumaes 6
The Radix Astragali 6 Herba Siphonostegiae 6
Fructus Hordei Germinatus 6 Endothelium corneum 6
Massa Medicata Fermentata (parched to brown) 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031186017A CN1190229C (en) | 2003-02-12 | 2003-02-12 | Medicine for curing hepatitis B |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031186017A CN1190229C (en) | 2003-02-12 | 2003-02-12 | Medicine for curing hepatitis B |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1456227A CN1456227A (en) | 2003-11-19 |
CN1190229C true CN1190229C (en) | 2005-02-23 |
Family
ID=29411326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031186017A Expired - Fee Related CN1190229C (en) | 2003-02-12 | 2003-02-12 | Medicine for curing hepatitis B |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1190229C (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100460010C (en) * | 2005-05-29 | 2009-02-11 | 王福山 | Chinese medicine composition for treating hepatitis B and viral hepatitis |
CN105412645A (en) * | 2015-12-04 | 2016-03-23 | 青岛安倍康生物医药技术有限公司 | Herba portulacae oral liquid for clearing heat and promoting diuresis, expelling toxin and protecting liver and preparation method of oral liquid |
CN107343948A (en) * | 2017-08-04 | 2017-11-14 | 成都市飞龙水处理技术研究所 | It is a kind of effectively to treat pill medicine of hepatitis B and preparation method thereof |
-
2003
- 2003-02-12 CN CNB031186017A patent/CN1190229C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1456227A (en) | 2003-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1190229C (en) | Medicine for curing hepatitis B | |
CN1839944A (en) | Granular composition for reducing blood fat and process for producing the same | |
CN1063954C (en) | Chinese patent medicine-powder preparation for curing hepatitis B | |
CN1686502A (en) | Medicine for fortifying human body immune function | |
CN1066628C (en) | Medicine for chronic hepatitis B and its preparation | |
CN1493315A (en) | Medicine for treating chronic hepatitis B | |
CN1051471C (en) | Drug composition for curing osteoporosis | |
CN1059104C (en) | Capsule for anti hepatitis B | |
CN1292766C (en) | Chinese medicinal preparation for treating viral myocarditis and its making method | |
CN1169555C (en) | A Chinese medicinal decoction pill for treating hepatitis B | |
CN1319587C (en) | Medicine powder for liver and spleen diseases | |
CN1302799C (en) | Oral Chinese medicinal composition for treating virus myocarditis | |
CN1074292C (en) | Cancer treating medicine capsule | |
CN100340286C (en) | Medicine for treating hepatitis B and its preparing process | |
CN1136939A (en) | Chinese drugs for curing hepatitis B | |
CN1969940A (en) | Antivirus pharmaceutical composition | |
CN1047944C (en) | Capsule for curing hepatitis | |
CN1195541C (en) | Medicine combination for treating chronic hepatitis B | |
CN1352966A (en) | Medicine for treating tracheitis and asthma | |
CN1150016C (en) | Medicine for treating fever caused by lupus erythematosus and other immunological disease | |
CN1340353A (en) | Orally-applied medicine for treating hepatism and its preparing process | |
CN1059590C (en) | Medicine for blood generation and preparing method | |
CN1251737C (en) | Chinese traditional medicine capsule for restoring the normal function of liver | |
CN1086949C (en) | Chinese medicine for hepatitis B and its preparation | |
CN1611258A (en) | Medicinal composition for treating exogenous febrile disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |